Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients

Bone Marrow Stroma Confers Resistance to Apo2 Ligand/TRAIL in Multiple Myeloma in Part by Regulating c-FLIP

(2014) L. E. Perez et al.   JOURNAL OF IMMUNOLOGY

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

(2011) J. Jakubikova et al.   BLOOD

New Antibody Conjugates in Cancer Therapy

(2011) Serengulam V. Govindan et al.   TheScientificWorldJOURNAL

Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy

(2010) Ludovic Ferrer et al.   CANCER

Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma

(2010) T. Rasmussen et al.   HAEMATOLOGICA

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

(2009) T. B. Bartel et al.   BLOOD

A Method to Correct for Radioactivity in Large Vessels That Overlap the Spine in Imaging-Based Marrow Dosimetry of Lumbar Vertebrae

(2008) R. F. Meredith et al.   JOURNAL OF NUCLEAR MEDICINE

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

(2008) R A Kyle et al.   LEUKEMIA

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE